Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention
- PMID: 20510240
- PMCID: PMC2905601
- DOI: 10.1016/j.rdc.2010.03.003
Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention
Abstract
In rheumatoid arthritis (RA), cells within the inflamed synovium and pannus elaborate a variety of cytokines, including tumor necrosis factor (TNF) alpha, interleukin (IL)-1, IL-6, and IL-17, that contribute to inflammation, and may directly affect bone. The receptor activator of NF-kappaB (RANK) ligand/RANK/osteoprotegerin pathway plays a critical role in regulating osteoclastogenesis in articular bone erosions in RA. Proinflammatory cytokines can modulate this pathway, and may also affect the ability of the osteoblast to repair bone at sites of articular erosion. In this review, the authors discuss the current understanding of pathogenic mechanisms of bone erosion in RA and examine current therapeutic approaches to prevent this damage.
References
-
- Gravallese EM, Monach PA. Rheumatoid synovitis and pannus. In: Hochberg MSA, Smolen J, Weinblatt M, Weisman M, editors. Rheumatology. 4. London, UK: Elsevier Ltd; 2008. pp. 841–65.
-
- Scott DL. Radiological progression in established rheumatoid arthritis. J Rheumatol Suppl. 2004 Mar;69:55–65. - PubMed
-
- Sambrook PN. The skeleton in rheumatoid arthritis: common mechanisms for bone erosion and osteoporosis? J Rheumatol. 2000 Nov;27(11):2541–2. - PubMed
-
- Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum. 1991 Feb;20(4):256–72. - PubMed
-
- Wollheim FA. Established and new biochemical tools for diagnosis and monitoring of rheumatoid arthritis. Curr Opin Rheumatol. 1996 May;8(3):221–5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
